Quality of Japanese clinical trials estimated from good clinical practice audit findings

American Journal of Therapeutics

Volumn 13, Issue 2, 2006, Pages 127-133

  Saito, Kazuyuki ^a   Kodama, Yasuo ^b   Ono, Shunsuke ^c   Mutoh, Mizue ^b   Kawashima, Susumu ^d   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

Author keywords

Good clinical practice; Japanese clinical trials; Research environment

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; GOOD CLINICAL PRACTICE; INFORMED CONSENT; JAPAN; MEDICAL AUDIT; PRIORITY JOURNAL; QUALITY CONTROL; CLINICAL TRIAL; HOSPITAL; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

CLINICAL TRIALS; GUIDELINES; HOSPITALS; JAPAN; QUALITY CONTROL; UNITED STATES;

EID: 33646568077     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200603000-00008     Document Type: Article

References (15)

1. International Conference on Harmonization (ICH) Harmonized Tripartite Guidelines (Step 4). Guidelines for Good Clinical Practice. Geneva: ICH Secretariat; 1996.
2. Ministry of Health, Labor and Welfare. MHLW Ordinance No. 28, March 27, 1997.
3. Ministry of Health, Labor and Welfare. Guideline for Good Clinical Practice. Pharmaceutical Affairs Bureau Notification No. 874. Tokyo: Ministry of Health, Labor and Welfare; 1989.
4. Ueda K. Experience of implementing ICH GCP in Japan. 1st Preliminary Conference on World Health Organization (WHO) GCP. Geneva, September 10-12, 2001.
5. Betsui H. Regarding the promoting plan for clinical trials of MHLW [Japanese]. Jpn J Clin Pharmacol Ther. 2003;34:509-510.
6. Kodama Y. Current status of GCP inspection [Japanese]. In: Cancer Frontier. Tokyo: Iyaku Journal; 2002:166-171.
7. Ono S, Kodama Y, Nagao T, et al. The quality of conduct in Japanese clinical trials: deficiencies found in GCP inspections. Control Clin Trials. 2002;23:29-41.
8. Saito K, Kodama Y, Ono S, et al. Recent changes of quality in Japanese clinical trials. Ann Pharmacother. 2004;38:151-155.
9. Saito K, Kodama Y, Ono S, et al. Current status of quality in Japanese clinical trials. Control Clin Trials. In press..
10. Onishi J. Current status of GCP inspection and the inspection of first notice of clinical trials [Japanese]. Iyakuhin Kenkyu. 2004;35:388-400.
11. Lepay DA. GCP compliance. FDA expectations and recent findings. Available at http://www.fda.gov/cder/ present/dia698/diafda2/index.htm (Accessed 2004 September 25).
12. Horowitz AM. Fraud and scientific misconduct in the United States. In: Lock S, Wells F, eds. Fraud and Misconduct in Medical Research, London: BMJ Publishing Group; 1996:144-165.
13. Ono S, Kodama Y. Clinical trials and the new good clinical practice guideline in Japan. Pharmacoeconomics. 2000;18:125-141.
14. Ohashi K, Kamiya A. Current status and the future of regional clinical trial network [Japanese]. Jpn J Clin Pharmacol Ther. 2004;35:295S-302S.
15. Kusuoka H. Present status of CRC in Japan: a survey. In: Towards the Globalization of Clinical Trial-International Symposium on Clinical Research of New Drugs, Record of International Symposium on Clinical Research II. Tokyo: Elsevier Science, MIX; 2001:28-41.